Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
ROSUVASTATIN (AS CALCIUM)
Milpharm Limited
C10AA07
ROSUVASTATIN (AS CALCIUM)
20 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
HMG CoA reductase inhibitors
Authorised
2012-08-24
PACKAGE LEAFLET: INFORMATION FOR THE USER ROSUVASTATIN AUROBINDO 5 MG FILM-COATED TABLETS ROSUVASTATIN AUROBINDO 10 MG FILM-COATED TABLETS ROSUVASTATIN AUROBINDO 20 MG FILM-COATED TABLETS ROSUVASTATIN AUROBINDO 40 MG FILM-COATED TABLETS rosuvastatin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again If you have any further questions, ask your doctor or pharmacist This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. What Rosuvastatin Aurobindo is and what it is used for 2. What you need to know before you take Rosuvastatin Aurobindo 3. How to take Rosuvastatin Aurobindo 4. Possible side effects 5. How to store Rosuvastatin Aurobindo 6. Contents of the pack and other information 1. WHAT ROSUVASTATIN AUROBINDO IS AND WHAT IT IS USED FOR Rosuvastatin Aurobindo belongs to a group of medicines called statins. You have been prescribed Rosuvastatin Aurobindo because: You have a HIGH CHOLESTEROL LEVEL . This means you are AT RISK FROM A HEART ATTACK OR STROKE . Rosuvastatin Aurobindo is used in adults, adolescents and children 6 years or older to treat high cholesterol. You have been advised to take a statin, because changing your diet and taking more exercise were not enough to correct your cholesterol levels. You should continue with your cholesterol-lowering diet and exercise while you are taking Rosuvastatin Aurobindo. WHY IS IT IMPORTANT TO KEEP TAKING ROSUVASTATIN AUROBINDO? Rosuvastatin Aurobindo is used to correct the levels of fatty substances in the blood called lipids, the most common of which is cholesterol. There are different types of cholesterol found in the blood – ‘bad’ cholesterol (LDL-C) and Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Rosuvastatin Aurobindo 20 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 20 mg rosuvastatin (as rosuvastatin calcium). Excipients with known effect: Each 20 mg tablet contains 91.755 mg lactose monohydrate, 0.029 mg allura red AC and 0.025 mg Sunset yellow FCF. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet Pink coloured, round shaped [diameter 7.4 mm], biconvex film-coated tablets, debossed with ‘J’ on one side and ‘55’ on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS TREATMENT OF HYPERCHOLESTEROLAEMIA Adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia (type IIa except heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. Homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Before treatment initiation the patient should be placed on a standard cholesterol-lowering diet that should continue during treatment. The dose should be individualised according to the goal of therapy and patient response, using current consensus guidelines. Rosuvastatin Aurobindo may be given at any time of day, with or without food. TREATMENT OF HYPERCHOLESTEROLAEMIA The recommended start dose is 5 or 10 mg orally once daily in both statin naïve or patients switched from another HMG CoA reductase inhibitor. The choice of start dose should take into account the individual patient's Read the complete document